Harrow outlines $350M-$365M 2026 revenue goal as sales force expansion and pipeline advances fuel momentum
Source: SeekingAlpha
2026-03-03 17:02:52 ET
More on Harrow Health
- Harrow, Inc. (HROW) Q4 2025 Earnings Call Transcript
- Harrow Shares Collapse, Another Opportunity?
- Harrow: Revisiting This Eyecare Growth Story Ahead Of Q4 Update
- Harrow Health GAAP EPS of $0.17 misses by $0.20, revenue of $89.09M beats by $0.67M
- Seeking Alpha’s Quant Rating on Harrow Health
Read the full article on Seeking Alpha
For further details see:
Harrow outlines $350M–$365M 2026 revenue goal as sales force expansion and pipeline advances fuel momentum
Harrow Health Inc.
NASDAQ: HROW
HROW Trading
-6.24% G/L:
$34.26 Last:
884,096 Volume:
$35.63 Open:
